What Is Papillary Renal Cell Carcinoma?
Papillary renal cell carcinoma (pRCC) is the second most common type of kidney cancer, accounting for about 10% to 15% of adult cases. It is called “papillary” because the tumor cells often grow in finger-like projections, or papillae, when viewed under a microscope.
Unlike the more common clear cell renal cell carcinoma, pRCC has different genetic features, growth patterns, and treatment responses. It can sometimes be less aggressive, but certain forms may behave more unpredictably.
Papillary RCC is no longer classified simply as “Type 1” or “Type 2,” as newer research shows that it includes a diverse group of subtypes with overlapping features. These subtypes may have different genetic mutations and biological behavior, but the term “papillary RCC” is still widely used in clinical settings.
This type of kidney cancer may occur sporadically or as part of an inherited condition, such as hereditary papillary renal cell carcinoma (HPRCC). People with HPRCC often develop tumors in both kidneys or have multiple tumors in the same kidney.
Papillary RCC is often discovered incidentally during imaging for unrelated health concerns. In other cases, it may cause symptoms such as:
- Blood in the urine
- Flank or back pain
- A lump in the side or abdomen
Treatment depends on the tumor size and stage. Small, localized tumors are typically managed with surgical removal, either partial or full nephrectomy. For advanced cases, options may include targeted therapies or immunotherapy, though these may be less effective than in clear cell RCC.
The prognosis for papillary RCC varies depending on tumor grade, genetic features, and whether it has spread. Many localized cases are successfully treated with surgery alone.
Looking for more questions?
Visit our Kidney Cancer Questions page for all other topics explained in plain language.
Comments
Post a Comment